Johnson & Johnson  

(Public, NYSE:JNJ)   Watch this stock  
Find more results for JNJ
129.91
-0.92 (-0.70%)
After Hours: 129.91 0.00 (0.00%)
Feb 21, 5:05PM EST  
NYSE real-time data - Disclaimer
Currency in USD
Range 129.86 - 132.43
52 week 118.32 - 148.32
Open 130.80
Vol / Avg. 6.57M/9.52M
Mkt cap 349.01B
P/E 336.46
Div/yield 0.84/2.59
EPS 0.39
Shares 2.69B
Beta 0.74
Inst. own 69%
Apr 27, 2018
Johnson & Johnson Annual Shareholders Meeting (Estimated) - 10:00AM EDT - Add to calendar
Apr 17, 2018
Q1 2018 Johnson & Johnson Earnings Release - 9:30AM EDT - Add to calendar
Apr 17, 2018
Q1 2018 Johnson & Johnson Earnings Call - 8:30AM EDT - Add to calendar
Mar 13, 2018
Johnson & Johnson at Barclays Global Healthcare Conference - 10:15AM EDT - Add to calendar
Mar 13, 2018
Johnson & Johnson at Cowen Health care Conference - 10:00AM EDT - Add to calendar
Feb 27, 2018
Johnson & Johnson at Credit Suisse Global Healthcare Conference Add to calendar
Feb 26, 2018
Johnson & Johnson at CECP CEO Investor Forum - 1:40PM EST - Add to calendar
Feb 22, 2018
Johnson & Johnson at Consumer Analyst Group of New York Conference - 2:00PM EST - Add to calendar
Feb 21, 2018
Johnson & Johnson at RBC Capital Markets 2018 Global Healthcare Conference
Feb 14, 2018
Johnson & Johnson at Leerink Partners Global Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q4 (Dec '17) 2017
Net profit margin -53.05% 1.70%
Operating margin 12.68% 23.12%
EBITD margin - 32.39%
Return on average assets - -
Return on average equity - -
Employees 126,400 -
CDP Score - A-

Address

1 Johnson And Johnson Plz
NEW BRUNSWICK, NJ 08933-0001
United States - Map
+1-732-5242455 (Phone)
+1-732-2140332 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Officers and directors

Alex Gorsky Chairman of the Board, Chief Executive Officer
Age: 56
Bio & Compensation  - Reuters
Dominic J. Caruso Chief Financial Officer, Executive Vice President
Age: 59
Bio & Compensation  - Reuters
Peter M. Fasolo Ph.D. Chief Human Resource Officer, Executive Vice President
Age: 54
Bio & Compensation  - Reuters
Paulus A. Stoffels Executive Vice President, Chief Scientific Officer
Age: 55
Bio & Compensation  - Reuters
Michael H. Ullmann Executive Vice President, General Counsel
Age: 58
Bio & Compensation  - Reuters
Joaquin Duato Executive Vice President, Worldwide Chairman - Pharmaceuticals
Age: 54
Bio & Compensation  - Reuters
Jorge S. Mesquita Executive Vice President, Worldwide Chairman - Consumer
Age: 55
Bio & Compensation  - Reuters
Sandra E. Peterson Executive Vice President - Group Worldwide Chairman
Age: 58
Bio & Compensation  - Reuters
Joseph Wolk Vice President - Investor Relations
Bio & Compensation  - Reuters
Anne M. Mulcahy Lead Independent Director
Age: 64
Bio & Compensation  - Reuters